journal
MENU ▼
Read by QxMD icon Read
search

Blood Cancer Journal

journal
https://www.readbyqxmd.com/read/29330482/normal-karyotype-in-myelofibrosis-is-prognostic-integrity-affected-by-the-number-of-metaphases-analyzed
#1
LETTER
Maura Nicolosi, Mythri Mudireddy, Naseema Gangat, Animesh Pardanani, Curtis A Hanson, Rhett P Ketterling, Ayalew Tefferi
No abstract text is available yet for this article.
January 12, 2018: Blood Cancer Journal
https://www.readbyqxmd.com/read/29330358/pathogenesis-of-bone-disease-in-multiple-myeloma-from-bench-to-bedside
#2
REVIEW
Evangelos Terpos, Ioannis Ntanasis-Stathopoulos, Maria Gavriatopoulou, Meletios A Dimopoulos
Osteolytic bone disease is the hallmark of multiple myeloma, which deteriorates the quality of life of myeloma patients, and it affects dramatically their morbidity and mortality. The basis of the pathogenesis of myeloma-related bone disease is the uncoupling of the bone-remodeling process. The interaction between myeloma cells and the bone microenvironment ultimately leads to the activation of osteoclasts and suppression of osteoblasts, resulting in bone loss. Several intracellular and intercellular signaling cascades, including RANK/RANKL/OPG, Notch, Wnt, and numerous chemokines and interleukins are implicated in this complex process...
January 12, 2018: Blood Cancer Journal
https://www.readbyqxmd.com/read/29321554/mutations-in-dnmt3a-u2af1-and-ezh2-identify-intermediate-risk-acute-myeloid-leukemia-patients-with-poor-outcome-after-cr1
#3
Caner Saygin, Cassandra Hirsch, Bartlomiej Przychodzen, Mikkael A Sekeres, Betty K Hamilton, Matt Kalaycio, Hetty E Carraway, Aaron T Gerds, Sudipto Mukherjee, Aziz Nazha, Ronald Sobecks, Christopher Goebel, Donna Abounader, Jaroslaw P Maciejewski, Anjali S Advani
Intermediate-risk acute myeloid leukemia (IR-AML) is a clinically heterogeneous disease, for which optimal post-remission therapy is debated. The utility of next-generation sequencing information in decision making for IR-AML has yet to be elucidated. We retrospectively studied 100 IR-AML patients, defined by European Leukemia Net classification, who had mutational information at diagnosis, received intensive chemotherapy and achieved complete remission (CR) at Cleveland Clinic (CC). The Cancer Genome Atlas (TCGA) data were used for validation...
January 10, 2018: Blood Cancer Journal
https://www.readbyqxmd.com/read/29321547/polycythemia-vera-treatment-algorithm-2018
#4
REVIEW
Ayalew Tefferi, Alessandro M Vannucchi, Tiziano Barbui
Recently reported mature survival data have confirmed the favorable prognosis in polycythemia vera (PV), with an estimated median survival of 24 years, in patients younger than age 60 years old. Currently available drugs for PV have not been shown to prolong survival or alter the natural history of the disease and are instead indicated primarily for prevention of thrombosis. Unfortunately, study endpoints that are being utilized in currently ongoing clinical trials in PV do not necessarily target clinically or biologically relevant outcomes, such as thrombosis, survival, or morphologic remission, and are instead focused on components of disease palliation...
January 10, 2018: Blood Cancer Journal
https://www.readbyqxmd.com/read/29321520/essential-thrombocythemia-treatment-algorithm-2018
#5
REVIEW
Ayalew Tefferi, Alessandro M Vannucchi, Tiziano Barbui
Current drug therapy for myeloproliferative neoplasms, including essential thrombocythemia (ET) and polycythemia vera (PV), is neither curative nor has it been shown to prolong survival. Fortunately, prognosis in ET and PV is relatively good, with median survivals in younger patients estimated at 33 and 24 years, respectively. Therefore, when it comes to treatment in ET or PV, less is more and one should avoid exposing patients to new drugs that have not been shown to be disease-modifying, and whose long-term consequences are suspect (e...
January 10, 2018: Blood Cancer Journal
https://www.readbyqxmd.com/read/29288251/prognostic-impacts-and-dynamic-changes-of-cohesin-complex-gene-mutations-in-de-novo-acute-myeloid-leukemia
#6
LETTER
Cheng-Hong Tsai, Hsin-An Hou, Jih-Luh Tang, Yuan-Yeh Kuo, Yu-Chiao Chiu, Chien-Chin Lin, Chieh-Yu Liu, Mei-Hsuan Tseng, Tzung-Yi Lin, Ming-Chih Liu, Chia-Wen Liu, Liang-In Lin, Ming Yao, Chi-Cheng Li, Shang-Yi Huang, Bor-Sheng Ko, Szu-Chun Hsu, Chien-Ting Lin, Shang-Ju Wu, Chien-Yuan Chen, Woei Tsay, Eric Y Chuang, Wen-Chien Chou, Hwei-Fang Tien
No abstract text is available yet for this article.
December 29, 2017: Blood Cancer Journal
https://www.readbyqxmd.com/read/29282357/risk-factors-for-arterial-versus-venous-thrombosis-in-polycythemia-vera-a-single-center-experience-in-587-patients
#7
S Cerquozzi, D Barraco, T Lasho, C Finke, C A Hanson, R P Ketterling, A Pardanani, N Gangat, A Tefferi
In a recent International Working Group on Myeloproliferative Neoplasms Research and Treatment (IWG-MRT) study, prior arterial events and hypertension were predictors of subsequent arterial thrombosis whereas prior venous events and age ≥65 years predicted venous thrombosis in polycythemia vera (PV). In the current study, we sought to validate the above findings and identify additional predictors of arterial versus venous thrombosis. At a median follow up of 109 months, thrombosis after diagnosis occurred in 128 (22%) patients; 82 (14%) arterial and 57 (10%) venous events...
December 27, 2017: Blood Cancer Journal
https://www.readbyqxmd.com/read/29269781/anp32a-dysregulation-contributes-to-abnormal-megakaryopoiesis-in-acute-megakaryoblastic-leukemia
#8
LETTER
Xueqin Sun, Bin Lu, Cuijuan Han, Wanlin Qiu, Qi Jin, Dengju Li, Qiubai Li, Qiong Yang, Qiang Wen, Puneet Opal, Ameet R Kini, John D Crispino, Zan Huang
No abstract text is available yet for this article.
December 22, 2017: Blood Cancer Journal
https://www.readbyqxmd.com/read/29263371/aggressive-nk-cell-leukemia-clinical-subtypes-molecular-features-and-treatment-outcomes
#9
LETTER
Y-T Tang, D Wang, H Luo, M Xiao, H-S Zhou, D Liu, S-P Ling, N Wang, X-L Hu, Y Luo, X Mao, Q-L Ao, J Huang, W Zhang, L-S Sheng, L-J Zhu, Z Shang, L-L Gao, P-L Zhang, M Zhou, K-G Zhou, L-G Qiu, Q-F Liu, H-Y Zhang, J-Y Li, J Jin, L Fu, W-L Zhao, J-P Chen, X Du, G Huang, Q-F Wang, J-F Zhou, L Huang
No abstract text is available yet for this article.
December 21, 2017: Blood Cancer Journal
https://www.readbyqxmd.com/read/29259173/cd19-negative-relapse-of-pediatric-b-cell-precursor-acute-lymphoblastic-leukemia-following-blinatumomab-treatment
#10
LETTER
E Mejstríková, O Hrusak, M J Borowitz, J A Whitlock, B Brethon, T M Trippett, G Zugmaier, L Gore, A von Stackelberg, F Locatelli
No abstract text is available yet for this article.
December 20, 2017: Blood Cancer Journal
https://www.readbyqxmd.com/read/29249804/marked-elevation-of-serum-lactate-dehydrogenase-in-primary-myelofibrosis-clinical-and-prognostic-correlates
#11
LETTER
Sahrish Shah, Mythri Mudireddy, Curtis A Hanson, Rhett P Ketterling, Naseema Gangat, Animesh Pardanani, Ayalew Tefferi
No abstract text is available yet for this article.
December 18, 2017: Blood Cancer Journal
https://www.readbyqxmd.com/read/29249799/mutations-and-karyotype-in-myelodysplastic-syndromes-tp53-clusters-with-monosomal-karyotype-runx1-with-trisomy-21-and-sf3b1-with-inv-3-q21q26-2-and-del-11q
#12
LETTER
Ayalew Tefferi, Dame Idossa, Terra L Lasho, Mythri Mudireddy, Christy Finke, Sahrish Shah, Maura Nicolosi, Mrinal M Patnaik, Animesh Pardanani, Naseema Gangat, Curt A Hanson, Rhett P Ketterling
No abstract text is available yet for this article.
December 18, 2017: Blood Cancer Journal
https://www.readbyqxmd.com/read/29242635/myd88-mutations-predict-unfavorable-prognosis-in-chronic-lymphocytic-leukemia-patients-with-mutated-ighv-gene
#13
LETTER
Shu-Chao Qin, Yi Xia, Yi Miao, Hua-Yuan Zhu, Jia-Zhu Wu, Lei Fan, Chun Qiao, Wei Xu, Jian-Yong Li
No abstract text is available yet for this article.
December 15, 2017: Blood Cancer Journal
https://www.readbyqxmd.com/read/29242623/clinical-and-radiological-responses-to-oral-methotrexate-alone-or-in-combination-with-other-agents-in-erdheim-chester-disease
#14
LETTER
Gaurav Goyal, Mithun V Shah, Timothy G Call, C Christopher Hook, William J Hogan, Ronald S Go
No abstract text is available yet for this article.
December 15, 2017: Blood Cancer Journal
https://www.readbyqxmd.com/read/29242616/anemia-in-myelofibrosis-prevalence-the-u2af1-connection-new-treatments
#15
EDITORIAL
Ayalew Tefferi
No abstract text is available yet for this article.
December 15, 2017: Blood Cancer Journal
https://www.readbyqxmd.com/read/29242603/development-of-expression-based-biomarkers-of-dasatinib-response-in-hematologic-malignancies
#16
LETTER
Monica K Akre, Amit Mitra, Wen Wang, Chad L Myers, Brian Van Ness
No abstract text is available yet for this article.
December 15, 2017: Blood Cancer Journal
https://www.readbyqxmd.com/read/29242598/mismatched-unrelated-donor-allogeneic-stem-cell-transplant-for-high-risk-haematological-malignancy-a-single-centre-experience
#17
LETTER
Heshani Mediwake, Cameron Curley, Jason Butler, Angela Mclean, Siok Tey, Geoffrey R Hill, Anthony Morton, Ashish Misra, Elango Subramoniapillai, Simon Durrant, Glen A Kennedy
No abstract text is available yet for this article.
December 15, 2017: Blood Cancer Journal
https://www.readbyqxmd.com/read/29242582/outcomes-of-patients-with-peripheral-t-cell-lymphoma-in-first-complete-remission-data-from-three-tertiary-asian-cancer-centers
#18
LETTER
Tiffany Tang, Lay Poh Khoo, Cindy Lim, Jun Soo Ham, Seok Jin Kim, Huangming Hong, Colin Phipps, Yuh Shan Lee, Miriam Tao, Richard Quek, Mohamad Farid, Tongyu Lin, Won Seog Kim, Soon Thye Lim
No abstract text is available yet for this article.
December 15, 2017: Blood Cancer Journal
https://www.readbyqxmd.com/read/29242575/asxl1-c-1934dup-p-gly646trpfs-12-a-true-somatic-alteration-requiring-a-new-approach
#19
LETTER
Costas K Yannakou, Kate Jones, Michelle McBean, Ella R Thompson, Georgina L Ryland, Ken Doig, John Markham, David Westerman, Piers Blombery
No abstract text is available yet for this article.
December 15, 2017: Blood Cancer Journal
https://www.readbyqxmd.com/read/29242558/the-nlr-and-lmr-ratio-in-newly-diagnosed-mm-patients-treated-upfront-with-novel-agents
#20
LETTER
Alessandra Romano, Nunziatina Laura Parrinello, Claudio Cerchione, Maria Letizia Consoli, Marina Parisi, Valeria Calafiore, Enrica Martino, Concetta Conticello, Francesco Di Raimondo, Giuseppe Alberto Palumbo
No abstract text is available yet for this article.
December 15, 2017: Blood Cancer Journal
journal
journal
43747
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"